Health care stocks were advancing late Tuesday afternoon, with the NYSE Health Care Index rising 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%.
The iShares Biotechnology ETF (IBB) eased 0.1%.
In corporate news, Asensus Surgical (ASXC) shares jumped nearly 16% after the company said its shareholders approved the planned merger with Karl Storz Endoscopy-America, a unit of Karl Storz SE & Co.
Eli Lilly (LLY) said Tuesday that results from a three-year phase 3 trial showed that weekly tirzepatide injections reduced the risk of developing type 2 diabetes by 94% in obese or overweight adults with pre-diabetes compared to a placebo. Its shares popped 3.2%.
Johnson & Johnson (JNJ) shares added 0.4%. The company said Tuesday it agreed to buy heart technology firm V-Wave for up to $1.7 billion, strengthening the health care products conglomerate's cardiovascular position.
Titan Pharmaceuticals (TTNP) shares surged 101% after the company said late Monday that it signed an agreement for a business combination with Malaysian firm KE.
Comments